Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
As world leaders enter climate talks, people in poverty have the most at stake
- yesterday, 11:32 PM
- globalnews.ca
- 0
No comments